Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:53:35 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Q:EXAS - EXACT SCIENCES CORP - https://www.exactsciences.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
EXAS - Q5.0101.81·103.341.0103.18+0.520.54,725.3481,50324,219102.75  103.42  102.3425102.73  38.8819:52:54Feb 0315 min RT 2¢

Recent Trades - Last 10 of 24219
Time ETExPriceChangeVolume
19:52:54Q102.0719-0.58811
19:43:22Q102.655-0.0051
18:27:49Q102.680.021
18:17:18Q101.81-0.851
16:11:00Q103.180.5229,000
16:10:04Q103.180.521
16:10:04Q103.180.521
16:10:04Q103.180.521
16:10:04Q103.180.521
16:04:42Q103.180.521

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-03 14:32U:EXASNews ReleaseExact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests
2026-02-03 09:03U:EXASNews ReleaseOncotype DX Breast Recurrence Score(TM) Test Surpasses 2 Million Patients Worldwide
2025-12-11 17:30U:EXASNews ReleaseExact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect(TM) MRD Test in Early Triple-Negative Breast Cancer at SABCS
2025-11-24 16:35U:EXASNews ReleaseExact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium
2025-11-20 07:30U:EXASNews ReleaseAbbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments
2025-11-10 07:00U:EXASNews ReleaseExact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome's Blood-Based Colorectal Cancer Screening Tests
2025-11-07 08:00U:EXASNews ReleaseExact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test
2025-11-04 07:00U:EXASNews ReleaseExact Sciences to Participate in November Investor Conference
2025-11-03 16:05U:EXASNews ReleaseExact Sciences Announces Third Quarter 2025 Results
2025-10-27 07:00U:EXASNews ReleaseExact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps
2025-10-08 07:00U:EXASNews ReleaseExact Sciences Schedules Third Quarter 2025 Earnings Call
2025-10-07 06:59U:EXASNews ReleaseNew Study in Journal of the National Cancer Institute Finds Cologuard Plus(TM) Provides the Most Life-Years Gained with the Fewest Colonoscopies
2025-09-22 07:00U:EXASNews ReleaseHorror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard(TM) Test
2025-09-10 06:30U:EXASNews ReleaseExact Sciences Launches Cancerguard(TM), First-of-Its-Kind Multi-Cancer Early Detection Blood Test
2025-08-19 06:00U:EXASNews ReleaseExact Sciences to Participate in September Investor Conferences
2025-08-06 16:05U:EXASNews ReleaseExact Sciences Announces Second Quarter 2025 Results
2025-08-06 16:05U:EXASNews ReleaseExact Sciences Announces Exclusive License with Freenome for Blood-Based Colorectal Cancer Screening Tests
2025-07-31 07:00U:EXASNews ReleaseExact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus(TM) Test
2025-07-14 06:00U:EXASNews ReleaseExact Sciences Schedules Second Quarter 2025 Earnings Call
2025-07-09 06:00U:EXASNews ReleaseExact Sciences Announces Medicare Coverage for Oncodetect(TM) Molecular Residual Disease Test in Colorectal Cancer